Molecular basis for the autonomous promotion of cell proliferation by angiogenin

Trish T Hoang1, Ronald T Raines2,3

  • 1Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.

Nucleic Acids Research
|December 5, 2016
PubMed

Insights

This study reveals a novel autonomous pathway where angiogenin (ANG) directly causes epigenetic changes, promoting cell proliferation. Phosphorylation allows ANG to bypass inhibitors, enter the nucleus, and alter gene expression for therapeutic potential.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Epigenetics

Background:

  • Canonical growth factors typically signal indirectly through cell surface receptors.
  • Angiogenin (ANG), a ribonuclease, is known to promote cell proliferation, neovascularization, and neuroprotection.
  • Intracellular ANG is normally inhibited by a ribonuclease inhibitor protein.

Purpose of the Study:

  • To elucidate the autonomous signaling pathway of angiogenin (ANG).
  • To investigate the mechanism by which ANG affects epigenetic changes and cell proliferation.
  • To explore the potential therapeutic applications of this novel pathway.

Main Methods:

  • Investigated the intracellular localization and activity of ANG.
  • Utilized phosphorylation assays to determine the role of kinases (PKC, CDK) in ANG regulation.
  • Analyzed the effect of ANG on ribosomal DNA (rDNA) transcription and nucleolar remodeling complex recruitment.

Main Results:

  • Phosphorylation by protein kinase C and cyclin-dependent kinase enables ANG to evade its inhibitor.
  • Phosphorylated ANG translocates to the nucleus and specifically cleaves promoter-associated RNA.
  • Cleavage of promoter-associated RNA derepresses rDNA transcription, leading to increased cell proliferation.

Conclusions:

  • ANG utilizes an unprecedented autonomous pathway for signal transduction, involving internalization, phosphorylation-dependent localization, and direct epigenetic modification.
  • This mechanism offers new insights into the regulation of cell proliferation.
  • The findings suggest novel therapeutic strategies for cancers and neurological disorders by targeting this pathway.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K